InMode (INMD) Net Margin (2018 - 2026)

InMode (INMD) posted quarterly Net Margin of 14.1% for Q1 2026, down 928.0% year-on-year from 1.7% in Q1 2025, and down 58.83% on a QoQ basis from 34.24% in Q4 2025.

InMode (INMD) Net Margin (2018 - 2026) Analysis & Trends

InMode (INMD) has reported Net Margin for 9 consecutive years, with 14.1% the latest figure, recorded in Q1 2026.

  • Quarterly Net Margin fell 928.0% year-over-year to 14.1% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 25.55% (up 653.0% YoY) and the FY2025 annual result came in at 34.23%, up 747.0% from the prior year.
  • Net Margin fell to 14.1% in Q1 2026 per INMD's latest filing, from 34.24% in the prior quarter.
  • Over the last five years, Net Margin for INMD reached as high as 51.4% in Q4 2023 and fell as low as 18.75% in Q4 2024.
  • A 5-year average of 30.13% and a median of 34.24% in 2025 frame the typical range for Net Margin.
  • Annual changes were most pronounced in 2024 — Net Margin tumbled 7015 bps — and 2025, when it soared 5299 bps.
  • Year by year, Net Margin stood at 28.23% in 2022, then soared by 82 bps to 51.4% in 2023, then tumbled by 136 bps to 18.75% in 2024, then soared by 283 bps to 34.24% in 2025, then sank by 59 bps to 14.1% in 2026.
  • According to Business Quant data, Net Margin over the past three periods registered 14.1%, 34.24%, and 23.47% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 9.65%
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 12.38%
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 12.84%
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 25.77%
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 16.74%
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 3.87%
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 8.01%
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 InMode 956,721.10 -479.17 Mn 61.55 Mn 14.10%

Historic Data

Download Data
DateValue
Mar 31, 2026 14.10%
Dec 31, 2025 34.24%
Sep 30, 2025 23.47%
Jun 30, 2025 27.97%
Mar 31, 2025 23.37%
Dec 31, 2024 -18.75%
Sep 30, 2024 39.15%
Jun 30, 2024 27.55%
Mar 31, 2024 29.52%
Dec 31, 2023 51.40%
Sep 30, 2023 37.79%
Jun 30, 2023 40.95%
Mar 31, 2023 38.19%
Dec 31, 2022 28.23%
Sep 30, 2022 40.24%
Jun 30, 2022 38.79%
Mar 31, 2022 36.05%
Dec 31, 2021 47.66%
Sep 30, 2021 47.48%
Jun 30, 2021 46.87%